Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab
Clinical trial NCT07013123 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07013123
- Sponsor
- University Hospital, Montpellier
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2029-08-18
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.